Edition:
India

Veru Inc (VERU.OQ)

VERU.OQ on NASDAQ Stock Exchange Capital Market

2.36USD
8:57pm IST
Change (% chg)

$0.07 (+3.06%)
Prev Close
$2.29
Open
$2.22
Day's High
$2.36
Day's Low
$2.22
Volume
19,483
Avg. Vol
25,705
52-wk High
$2.99
52-wk Low
$0.90

Select another date:

Wed, May 9 2018

BRIEF-Veru Reports Q2 Loss Per Share $0.07

* VERU INC Q2 REVENUE $2.6 MLN VS $2.4 MLN Source text for Eikon: Further company coverage:

BRIEF-U.S. FDA Grants Fee Waiver For Tamsulosin Drs New Drug Application

* FDA GRANTS FEE WAIVER FOR TAMSULOSIN DRS NEW DRUG APPLICATION

BRIEF-Veru Says On March 5 Entered Into Credit Agreement For Synthetic Royalty Financing Transaction

* VERU SAYS ON MARCH 5, ENTERED INTO CREDIT AGREEMENT FOR SYNTHETIC ROYALTY FINANCING TRANSACTION - SEC FILING

BRIEF-Veru Q1 Loss Per Share $0.08

* REMAIN ON TRACK TO FILE WITH FDA COMPANY'S FIRST NDA FOR TAMSULOSIN DRS IN 2018

BRIEF-Veru to Present At 2018 Genitourinary Cancers Symposium

* VERU ANNOUNCES PRESENTATION OF DATA DEMONSTRATING EFFICACY OF VERU-111 IN A TAXANE RESISTANT HUMAN PROSTATE CANCER MODEL AT THE 2018 GENITOURINARY CANCERS SYMPOSIUM

BRIEF-Veru reports Q4 Loss Per Share $0.10

* VERU REPORTS FISCAL 2017 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS

BRIEF-Veru Inc Files For Non-Timely 10-K

* VERU - DUE TO TECHNICAL DIFFICULTIES AT THIRD PARTY FILING AGENT, CO'S 10-K WAS TRANSMITTED, RECEIVED FOR FILING ON EDGAR AT 5:33 PM ET ON DEC 29, 2017 Source text (http://bit.ly/2EzynHN) Further company coverage:

Select another date: